Cogent Biosciences, Inc.
USD32.26
-0.50 (-1.53%)
CEO
Andrew R. Robbins
IPO Date
2018-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.80
Prev. Close
$32.76
Day Low
$31.43
Day High
$32.80
52W Low
$5.49
52W High
$43.73
Market Cap
$5.51B
Volume
2.46M
| 160,000 |
| $0.00 |
| 3 Apr 2026 | Ferrante Karen Jean | director | A-Award | Acquired | 686 | $35.24 |
| 31 Mar 2026 | Fairmount Funds Management LLC | director | C-Conversion | Acquired | 7,000,000 | $0.00 |
| 31 Mar 2026 | Fairmount Funds Management LLC | director | S-Sale | Disposed | 7,000,000 | $34.66 |
| 31 Mar 2026 | Fairmount Funds Management LLC | director | C-Conversion | Disposed | 28,000 | $0.00 |
| 22 Jan 2026 | Fairmount Funds Management LLC | director | S-Sale | Disposed | 3,500,000 | $36.40 |
| 5 Jan 2026 | Ferrante Karen Jean | director | A-Award | Acquired | 643 | $34.74 |
| 30 Dec 2025 | Kearns Evan | Chief Legal Officer | S-Sale | Disposed | 65,000 | $38.70 |
| 30 Dec 2025 | Green John L. | Chief Financial Officer | S-Sale | Disposed | 77,000 | $38.68 |